The deadline for all BC patients to transition from biologic to biosimilar drugs is in 30 days (November 25th, 2019). Here’s what this means for you.
Any patient currently taking a biologic medication, a classification of biologically active medicine prescribed for illnesses ranging from psoriasis to cancer, will be required to change their drug treatment to the biosimilar equivalent option. This is a cost-savings measure taken by the BC Government— and is a change that could potentially expand treatment options for some, while taking freedom of choice away from others.
How have you been affected by this change?
CARP wants to hear from you. Have you or a loved one already switched your medication? Has this been a simple process? How has it affected your treatment? Have you experienced other impacts?
Any information shared will help to inform CARP’s work to ensure that governments employ an age-aware approach to policy, programs and funding for all elements of the health care continuum: preventive, acute, chronic, long-term and end-of-life care.